Abstract
Cancer therapy has taken a major leap forward in recent years. However, to fully unfold the concept of precision medicine, non-invasive methods for characterisation of tumours and metastases are needed. PET imaging offers this. Whereas 18F-fluorodeoxyglucose-PET is currently used in most cancer types for diagnosing or staging, we expect new tracers to become available in the clinical routine, supporting tailoring and monitoring of cancer therapies.
| Bidragets oversatte titel | Nuclear medical diagnostic and cancer precision medicine |
|---|---|
| Originalsprog | Dansk |
| Artikelnummer | V06180463 |
| Tidsskrift | Ugeskrift for Laeger |
| Vol/bind | 180 |
| Udgave nummer | 46 |
| Antal sider | 4 |
| ISSN | 0041-5782 |
| Status | Udgivet - 2018 |